Fulcrum Therapeutics
FULC
FULC
121 hedge funds and large institutions have $402M invested in Fulcrum Therapeutics in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 36
29% less capital invested
Capital invested by funds: $570M → $402M (-$168M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
121
Holding in Top 10
2
Calls
$27.2M
Puts
$1.92M
Top Buyers
| 1 | +$20.2M | |
| 2 | +$4.86M | |
| 3 | +$4.61M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.3M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$3.11M |
Top Sellers
| 1 | -$5.2M | |
| 2 | -$5M | |
| 3 | -$4.65M | |
| 4 |
Millennium Management
New York
|
-$3.07M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.97M |